GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » Price-to-Tangible-Book
中文

Kamada (Kamada) Price-to-Tangible-Book : 2.86 (As of Apr. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Kamada Price-to-Tangible-Book?

As of today (2024-04-24), Kamada's share price is $5.18. Kamada's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.81. Hence, Kamada's Price to Tangible Book Ratio of today is 2.86.

The historical rank and industry rank for Kamada's Price-to-Tangible-Book or its related term are showing as below:

KMDA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.38   Med: 2.06   Max: 10.5
Current: 2.88

During the past 13 years, Kamada's highest Price to Tangible Book Ratio was 10.50. The lowest was 1.38. And the median was 2.06.

KMDA's Price-to-Tangible-Book is ranked worse than
58.76% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.32 vs KMDA: 2.88

A closely related ratio is called PB Ratio. As of today, Kamada's share price is $5.18. Kamada's Book Value per Sharefor the quarter that ended in Dec. 2023 was $4.25. Hence, Kamada's P/B Ratio of today is 1.22.


Kamada Price-to-Tangible-Book Historical Data

The historical data trend for Kamada's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Price-to-Tangible-Book Chart

Kamada Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.04 1.64 12.68 6.20 3.38

Kamada Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.20 7.06 7.22 3.20 3.38

Competitive Comparison of Kamada's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kamada's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kamada's Price-to-Tangible-Book falls into.



Kamada Price-to-Tangible-Book Calculation

Kamada's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=5.18/1.81
=2.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Kamada Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kamada's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Kamada (Kamada) Business Description

Traded in Other Exchanges
Address
2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Kamada (Kamada) Headlines

From GuruFocus

Kamada Announces Planned Transition of Chief Financial Officer

By Value_Insider Value_Insider 12-19-2022